The Obesity Society has appointed a new CEO, Sherlyn Celone-Arnold, and several key experts to its leadership team, enhancing its commitment to addressing obesity through innovative strategies and expert guidance.
Sherlyn Celone-Arnold, with over 20 years of experience, takes over as CEO, promising a culture of innovation, inclusion, and continuous improvement. She aims to address stigma and bias, advocating for people living with obesity while driving TOS' mission to advance evidence-based clinical care models.
A new oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist, Orforglipron, has demonstrated significant weight loss of 7.9% in individuals with diabetes and impaired glycemic control. The safety and tolerability of the medication are consistent with injectable therapies, making it a potentially accessible treatment option.
More than 20 leading organizations and providers urge the FDA to take action following the recent resolution of GLP-1 medicine shortages. Signatories include the Alliance for Women’s Health & Prevention, Association of Black Cardiologists, and National Hispanic Medical Association.
The FDA has resolved Novo Nordisk's Wegovy and Ozempic shortages, ensuring access to critical medications for obesity and diabetes treatment. The Obesity Society urges the FDA to enforce regulations against unauthorized GLP-1 compounders, highlighting concerns over safety and efficacy.
A list of evidence-based nutritional recommendations has been developed to assist clinicians in treating patients with anti-obesity medications. The recommendations aim to improve nutritional needs within the context of reduced food intake, and include ongoing monitoring of dietary intake and nutritional status.
A new study published in Obesity found that accumulating moderate to vigorous physical activity in the evening was associated with lowering day, night and overall blood glucose levels compared to being inactive. This association was stronger in those participants with impaired glucose regulation.
A new study finds that military health care beneficiaries are more prone to excessive pregnancy weight gain and substantial postpartum weight retention, leading to costly complications and fitness challenges. Researchers emphasize the importance of weight management before, during, and after pregnancy for military populations.
Researchers found that the hedonic overdrive model best explains obesity in male mice fed high-fat diets. The study reveals that dietary protein and carbohydrate, but not fat, drive overconsumption, contradicting the mass balance model of obesity.
A new study using adult Finnish twins has identified protective and detrimental factors that precede weight gain, providing valuable insights into how people can maintain a healthy weight. The researchers found that individuals who deviated from their genetically-informed BMI had a higher risk of obesity.
A study co-authored by past presidents of The Obesity Society shows that Wegovy can reduce existing heart disease in patients with obesity. The medication, semaglutide, was found to be life-saving and can benefit all sub-groups studied.
The SURMOUNT-3 study demonstrated a significant weight loss of 24.3% in participants administered tirzepatide, compared to 2.5% for placebo. The study also showed improvements in multiple health measures, including waist circumference and blood sugar levels.
Studies reveal hyper-connectivity of VTA with visual processing regions and hypo-connectivity with cognitive control regions in patients with obesity. This imbalance is associated with food craving and cognition, but not impulsivity or hunger.
Ten medical schools nationwide and internationally have been selected to participate in a two-year quality improvement project to refine and implement a competency-based obesity education curriculum. The program aims to improve the care of people living with obesity by educating future physicians.
A new study found that gastric bypass surgery is associated with a higher incidence of non-alcohol substance use disorder, particularly other psychoactive substance-related disorders. The study suggests healthcare professionals should consider this risk when caring for patients treated with gastric bypass surgery.
A new analysis of the STEP TEENS trial shows that nearly half (45%) of adolescents using semaglutide lost enough weight to drop below the clinical cut-off for obesity. Treatment with semaglutide reduced the proportion of participants with severe obesity from 37% to 14% after 68 weeks.
A new study found that gestational weight gain z scores, standardized by pre-pregnancy BMI, are associated with susceptibility to autism-related traits in children. Pregnant individuals and clinicians can benefit from healthy weight gain guidelines during pregnancy.
The Obesity Society joins European, US, and Canadian organizations in promoting the use of people-first language for pediatric overweight and obesity. This approach aims to minimize negative bias, stigma, and discrimination while acknowledging individuals as more than their weight or disease.
A recent study found that adolescents living in areas with healthier built environments are less likely to be obese and have healthier eating habits. The study suggests that strategies for addressing childhood obesity should focus on improving built environments.
A Slovenian population-scaled, school-based study found that providing additional physical education lessons to young children effectively prevents childhood obesity. The intervention increased BMI in both normal-weight and obese children, with maximal effects seen after three-to-four years of participation.
A new study found significant reductions in death rates from all causes and specific conditions like cardiovascular disease, diabetes, and cancer after bariatric surgery. Younger patients who underwent bariatric surgery were at increased risk of death from suicide, while mortality rates for males and females decreased significantly.
A new study found a significant weight loss of 8.8% among participants after six months, with improvements in health and vitality. The approach addresses biological antecedents of food intake and develops intrinsic motivation for behavior changes.
Experts recognize obesity as a prime inducer of CKD and related adverse outcomes, emphasizing the need for bridging common ground between nephrology and obesity medicine. Strategies include recognizing obesity as a chronic disease with targeted treatments and trained clinical extenders to promote effective care.
A new study found that a fully-automated online behavioral obesity treatment program led to significant weight loss among participants, with an average 12-week weight loss of 5.10%. The program addressed barriers in primary care, including limited resources and overburdened providers.
A new study examines childhood obesity disparities within integrated and segregated schools, finding larger gaps between Latino, Black, and Filipino children compared to White children. The study suggests that school segregation fosters obesogenic conditions disproportionately affecting these groups.
A study published in Obesity found that telemedicine can mitigate barriers to obesity care, including limited access to specialized care and high costs. Virtual interactions between patients and healthcare providers may be more cost-effective and lead to better weight loss outcomes.
A new study found a strong association between social determinants of health and obesity rates, with higher SDOH burden leading to increased obesity prevalence. The study analyzed data from nearly 165,000 adults in the US and found that middle-aged and non-Hispanic Black adults were more likely to be overweight or obese.
A recent study published by The Obesity Society found that metabolic adaptation after weight loss increases the time necessary to achieve weight-loss goals in premenopausal women. The study, which included 65 participants, revealed a significant delay in achieving weight-loss goals due to metabolic adaptation.
A new study found that incorporating frequent periods of enjoyable movement into daily life leads to better short-term and long-term weight loss compared to structured exercise. The intervention, which encouraged participants to move more often throughout the day, resulted in similar weight loss and improved maintenance relative to a h...
The Obesity Society's 39th Annual Meeting presents research on COVID-19 and its effects on obesity, including increased childhood obesity among severe cases. Researchers also examine changes in healthcare access for bariatric surgery patients and the effectiveness of telemedicine for weight management.
The 39th Annual Meeting of The Obesity Society will showcase innovative research results on obesity prevention and treatment. Over 500 oral and poster abstracts will be presented, highlighting the impact of diet, sleep, and lifestyle factors on weight loss.
A meta-analysis of pooled estimates found that healthcare professionals exhibit implicit weight bias, but the extent and nature of this bias are mixed. The study highlights the importance of addressing weight bias in healthcare settings to improve patient care and outcomes.
A study published in Obesity highlights the need for increased diversity in membership and leadership at obesity and nutrition-focused professional organizations. The researchers emphasize the importance of tracking racial and ethnic data to monitor progress in diversity efforts.
The Obesity Society's ninth annual journal symposium will highlight innovative research designs for preventing and treating obesity. Five honorees from the US and Canada will present their work, including studies on weight discrimination, sleep patterns, and hypothalamic gliosis.
Medically-supervised pediatric obesity treatment is associated with improved psychosocial health and reduced symptoms of depression, anxiety, and eating disorders. However, access to supervised weight management services is limited in the US, with fewer than 50 facilities available.
The Obesity Society's new position statement confirms COVID-19 vaccines are highly efficacious in individuals with and without obesity. Trials demonstrate similar vaccine efficacy in both groups against COVID-19-associated hospitalization and death.
A comprehensive review of 315 clinical trials found that most weight-loss supplements and therapies did not produce significant weight loss. Only 16 studies demonstrated significant results, with weight loss ranging from 0.3 to 4.93 kg.
A recent study found that successful weight losers sit significantly less during the week and weekends compared to those who are weight stable. Weight loss maintainers expended more calories per week in physical activity, suggesting that moving more may be key to long-term weight maintenance.
Researchers found that obesity-associated metabolic factors activate myeloid-derived suppressor cells, which can enhance cancer risk. Additionally, a prospective cohort study revealed meaningful differences in cancer risk by race and sex among obese adults.
A new Australian study found that changes in lifestyle patterns during early childhood are longitudinally associated with concurrent changes in body mass index (BMI) z scores. The study identified three trajectory groups of child lifestyle patterns and BMI z scores, with a healthy lifestyle pattern being the most distinctive in reducin...
A systematic review of randomized controlled studies found that digital self-monitoring using digital health tools was associated with significant weight loss. Digital tools, including apps, wearables, and websites, were used to track behaviors such as diet and physical activity.
A new study confirms that treatment with Bimagrumab is safe and effective for treating excess adiposity and metabolic disturbances in adult patients with obesity and type 2 diabetes. The medication achieved a nearly 21% decrease in body fat and a 6.5% reduction in body weight, along with a gain of lean mass.
The Obesity Society recognizes Roxane Gay for her powerful writing on obesity challenges, Ted Kyle for his influential newsletter ConscienHealth, and Rudolph Leibel for his groundbreaking discoveries on leptin and body weight regulation. These awardees have significantly contributed to understanding obesity.
Recent research highlights the significant effects of COVID-19 on people with obesity, including immune system impact and outcomes in critically ill patients. Top abstracts from ObesityWeek Interactive showcase the influence of pandemic lockdowns on lifestyle behaviors and eating habits.
The 38th Annual Meeting of The Obesity Society will present innovative scientific research results through oral and poster abstracts. These communications highlight new anti-obesity medication clinical trials and comparisons of weight loss diets.
The Obesity Society has announced four honorees for its annual symposium, which will present the latest insights into preventing and treating obesity. The honorees represent a range of topics, including the effects of obesogenic medication on weight change outcomes.
A new study published in Obesity found that an intensive lifestyle intervention (ILI) focused on weight loss lowered the incidence of obesity-related cancers in adults with overweight or obesity and type 2 diabetes. The ILI reduced cancer incidence by 16% compared to a Diabetes Support and Education comparison group.
A study found that African Americans with higher body mass index (BMI) were more likely to develop severe coronavirus disease 2019 (COVID-19) and require intensive care unit (ICU) admission. Obesity was identified as a significant determinant of disease severity in this population.
Researchers found that anti-obesity medications like phentermine and topiramate can significantly reduce weight regain in patients after Roux-en-Y gastric bypass surgery. The study, which analyzed nearly 1,200 patients, showed a 10% decrease in cumulative weight regain.
Researchers examined the impact of antibiotics during pregnancy and infancy on childhood obesity and found no association. Additionally, a study investigated the effects of bariatric surgery on mental health and recommended managing challenges through evaluation and support.